The authors evaluated the association between diabetes, prediabetes and testosterone levels.

This study assessed the link between metformin (Glucophage) use in hospitalized and non-hospitalized patients with diabetes and different outcomes due to coronavirus disease 2019 (COVID-19). The study showed that metformin use was associated with a protective effect in COVID-19 outcomes in patients with type 2 diabetes (T2D).

This study evaluated the effects of using regular acetaminophen (Paracetamol) on blood pressure (BP) in patients with hypertension (high BP). The data showed that regular daily acetaminophen use increased BP in these patients and increased the risk of cardiovascular disease when compared with placebo.

This study evaluated the effect of whole grain consumption in glycaemic (blood sugar) control of patients with diabetes. The data showed that whole grain consumption was beneficial for the control of blood glucose levels in these patients.

This study investigated if de-escalation (reducing the intensity) of dual antiplatelet therapy (DAPT) with clopidogrel (Plavix) might be better than ticagrelor (Brilique)-based antiplatelet therapy in stabilized patients with acute myocardial infarction (MI; heart attack) undergoing percutaneous coronary intervention (PCI). The data showed that a de-escalation strategy with clopidogrel plus aspirin significantly reduced the risk of bleeding events compared to ticagrelor plus aspirin in these patients.

This study compared the effects of vildagliptin (Zomelis) and glimepiride (Amaryl) on the rise and fall of blood glucose levels (glucose fluctuations) in patients with type 2 diabetes mellitus (T2DM). 

This study examined the effect of reduced insulin doses before and after intense exercise on post-exercise glucose (sugar), insulin, and inflammation levels in type 1 diabetes patients.

This study examined the effect of insulin delivery and blood glucose monitoring on the frequency of low blood glucose (hypoglycemia).

This review evaluated the effect of prolonged fenofibrate (Tricor) treatment on the need for retinal laser treatment for diabetic eye disease in patients with type 2 diabetes (T2D). The data showed a reduced need for retinal laser treatment in these patients compared to placebo.

This review evaluated the effectiveness of denosumab (Prolia) on bone mineral density (BMD) and joint destruction in patients with rheumatoid arthritis (RA). The authors concluded that denosumab treatment was linked to increased BMD and reduced joint destruction in patients with RA.